Nuzenio

Michael Severino Ceo

Michael Severino Ceo news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 17 latest news signals 15 publisher sources 100/100 entity strength

Latest news

Sarepta Therapeutics (SRPT) Brings In Michael Severino As Chief Executive Officer - simplywall.stsimplywall.st · Sat, 08 Aug 2026 10:47:29 GMTSarepta Therapeutics (SRPT) Names Michael Severino CEO Amid Gene Therapy Turbulence And Revenue Pressure - londoninsider.co.uklondoninsider.co.uk · Thu, 06 Aug 2026 19:31:19 GMTSarepta’s new CEO Michael Severino faces critical milestones to prove growth - Fierce PharmaFierce Pharma · Thu, 06 Aug 2026 15:15:32 GMTSarepta Therapeutics Announces Second Quarter 2026 Financial Results and Recent Corporate Developments - FinancialContentFinancialContent · Wed, 05 Aug 2026 20:05:00 GMTWeekly Recap: SRPT CEO equity grant and Morgan Stanley bullish on DMD catalysts - TradingViewTradingView · Mon, 03 Aug 2026 11:33:04 GMTLegend CEO departs without successor in place—Chutes & Ladders - Fierce BiotechFierce Biotech · Fri, 31 Jul 2026 12:29:45 GMTPeople on the Move: Michael Severino, M.D., Joins Sarepta Therapeutics as Chief Executive Officer - biobuzz.iobiobuzz.io · Thu, 30 Jul 2026 21:27:46 GMTSarepta Therapeutics, Inc. (SRPT) CEO gets 2,224,342 options, 756,104 RSUs - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Sat, 08 Aug 2026 10:47:29 GMTSarepta Therapeutics (SRPT) Brings In Michael Severino As Chief Executive Officer - simplywall.st
Thu, 06 Aug 2026 19:31:19 GMTSarepta Therapeutics (SRPT) Names Michael Severino CEO Amid Gene Therapy Turbulence And Revenue Pressure - londoninsider.co.uk
Thu, 06 Aug 2026 15:15:32 GMTSarepta’s new CEO Michael Severino faces critical milestones to prove growth - Fierce Pharma
Wed, 05 Aug 2026 20:05:00 GMTSarepta Therapeutics Announces Second Quarter 2026 Financial Results and Recent Corporate Developments - FinancialContent
Mon, 03 Aug 2026 11:33:04 GMTWeekly Recap: SRPT CEO equity grant and Morgan Stanley bullish on DMD catalysts - TradingView
Fri, 31 Jul 2026 12:29:45 GMTLegend CEO departs without successor in place—Chutes & Ladders - Fierce Biotech

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Michael Severino Ceo.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

15 distinct publisher/source names are currently connected to this entity page.